Point72 Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-520
Closed -$28.3K 2508
2023
Q3
$28.3K Buy
+520
New +$30.8K ﹤0.01% 2241
2023
Q2
Sell
-677
Closed -$34.9K 2504
2023
Q1
$34.9K Buy
+677
New +$32.9K ﹤0.01% 1856

Other funds holding LMAT

Point72 Asset Management's LMAT Position: Q4 2023 in Review

Point72 Asset Management sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 520 shares — an estimated $28.3K sold.

Point72 Asset Management first reported a position in LMAT in Q1 2023 and held it in 2 quarters. The position peaked at $34.9K in Q1 2023. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.

  • Point72 Asset Management reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 520 LeMaitre Vascular shares in Q4 2023, an estimated $28.3K.
  • Point72 Asset Management first reported a position in LeMaitre Vascular in Q1 2023 and held it in 2 quarters.
  • Point72 Asset Management's LeMaitre Vascular position peaked at $34.9K in Q1 2023.
  • 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.